<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR439/DRR439694/DRR439694_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR437/DRR437024/DRR437024_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR437/DRR437025/DRR437025_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR437/DRR437023/DRR437023_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR439/DRR439693/DRR439693_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR439/DRR439696/DRR439696_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR439/DRR439695/DRR439695_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR437/DRR437024/DRR437024_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR439/DRR439696/DRR439696_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR439/DRR439695/DRR439695_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR439/DRR439694/DRR439694_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR437/DRR437023/DRR437023_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR439/DRR439693/DRR439693_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/DRR437/DRR437025/DRR437025_2.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>Graduate School of Frontier Sciences, The University of Tokyo</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJDB15125</full_dataset_link><scientific_name>Homo sapiens</scientific_name><long_description>Adult T-cell leukemia/lymphoma (ATL) is characterized by a high frequency of chromosomal aberrations however, the molecular mechanisms underlying this chromosomal instability are poorly understood. We previously reported the presence of a biological link between the expression of CD30, which serves as a marker for ATL progression, and the actively proliferating fraction of HTLV-1-infected cells that display polylobulation. We demonstrate that CD30 signaling triggers chromosomal instability with clonal expansion in primary CD30-expressing ATL cells and clarifies the molecular mechanisms. Furthermore, we investigate the expression mechanism of CD30, whose gene name is TNFRSF8, using the ChIP-Sequence and Hi-C methods. This study highlights that CD30 signaling is one of the oncogenic factors of ATL progression with clonal evolution and that CD30 is a promising therapeutic target for ATL.</long_description><repository>ENA</repository></additional><is_claimable>false</is_claimable><name>Homo sapiens</name><description>The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma</description><dates><last_updated>2025-09-24</last_updated><first_public>2025-06-04</first_public></dates><accession>PRJDB15125</accession><cross_references><taxon>9606</taxon></cross_references></HashMap>